Kiniksa Pharmaceuticals, Ltd. (KNSA)
USD 19.48
(-3.94%)
USD 19.48
(-3.94%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 213.73 Million USD | 3.47% |
| 2022 | 173.21 Million USD | 488.28% |
| 2021 | 29.44 Million USD | 873.82% |
| 2020 | -3.8 Million USD | -16.04% |
| 2019 | -3.27 Million USD | -1046.5% |
| 2018 | -286 Thousand USD | -921.43% |
| 2017 | -28 Thousand USD | -27.27% |
| 2016 | -22 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 48.32 Million USD | -14.68% |
| 2024 Q2 | 66.17 Million USD | 36.95% |
| 2024 Q3 | 62.79 Million USD | -5.1% |
| 2023 Q4 | 56.63 Million USD | 39.34% |
| 2023 Q3 | 40.64 Million USD | -18.36% |
| 2023 Q1 | 41.3 Million USD | -13.31% |
| 2023 FY | 179.21 Million USD | 3.47% |
| 2023 Q2 | 49.78 Million USD | 20.53% |
| 2022 Q1 | 27.97 Million USD | 88.0% |
| 2022 FY | 173.21 Million USD | 488.28% |
| 2022 Q4 | 47.65 Million USD | -45.59% |
| 2022 Q3 | 87.57 Million USD | 299.1% |
| 2022 Q2 | 21.94 Million USD | -21.55% |
| 2021 FY | 29.44 Million USD | 873.82% |
| 2021 Q1 | -883 Thousand USD | 0.0% |
| 2021 Q2 | 5.23 Million USD | 693.2% |
| 2021 Q3 | 9.32 Million USD | 78.08% |
| 2021 Q4 | 14.87 Million USD | 59.5% |
| 2020 FY | -3.8 Million USD | -16.04% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 FY | -3.27 Million USD | -1046.5% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 FY | -286 Thousand USD | -921.43% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | -28 Thousand USD | -27.27% |
| 2016 FY | -22 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 120.47 Million USD | -77.412% |
| Jaguar Health, Inc. | 7.72 Million USD | -2667.154% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 32289.006% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 4274800.0% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 85.919% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -78.48% |
| ContextLogic Inc. | 59 Million USD | -262.263% |
| MiMedx Group, Inc. | 266.84 Million USD | 19.902% |
| MEI Pharma, Inc. | 49.32 Million USD | -333.302% |
| AlloVir, Inc. | -398 Thousand USD | 53802.261% |
| Novavax, Inc. | 639.93 Million USD | 66.601% |
| Aptorum Group Limited | -1.11 Million USD | 19274.424% |
| Ardelyx, Inc. | 106.66 Million USD | -100.387% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 11.216% |
| Psyence Biomedical Ltd. | -240.00 USD | 89056350.0% |
| Vaxcyte, Inc. | -75 Million USD | 384.98% |
| Precigen, Inc. | 106 Thousand USD | -201536.792% |
| Pharming Group N.V. | 220.1 Million USD | 2.894% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -41401.942% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -21082.854% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -94.708% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 217.82% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 41461.713% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | 265.021% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 571.561% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 1072.097% |
| Acelyrin, Inc. | -115 Thousand USD | 185956.522% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 37531.699% |
| Senti Biosciences, Inc. | -2.68 Million USD | 8066.269% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -5176.105% |
| AbCellera Biologics Inc. | 38.02 Million USD | -462.091% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 4554.669% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -178012.5% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -633.753% |
| Chimerix, Inc. | 324 Thousand USD | -65867.593% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -42991.734% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 260752.439% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 785.759% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 43542.073% |
| Elevation Oncology, Inc. | -39 Thousand USD | 548138.462% |
| Alkermes plc | 1.37 Billion USD | 84.452% |
| Fortress Biotech, Inc. | 57.85 Million USD | -269.445% |
| Fortress Biotech, Inc. | 57.85 Million USD | -269.445% |
| Agenus Inc. | 139.61 Million USD | -53.089% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -1189.347% |
| Dyadic International, Inc. | 922.95 Thousand USD | -23057.634% |
| ImmuCell Corporation | 4.39 Million USD | -4761.72% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -914.838% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 301.403% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 122343.956% |
| Immix Biopharma, Inc. | -5468.00 USD | 3908933.211% |
| Incyte Corporation | 3.44 Billion USD | 93.788% |
| IO Biotech, Inc. | -756 Thousand USD | 28371.825% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 556.318% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 1700.071% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 483794.668% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 317.615% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 388709.091% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -26550.249% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 40656.926% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -627.311% |
| NextCure, Inc. | -3.68 Million USD | 5901.71% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -1022.381% |
| Onconetix, Inc. | -1.12 Million USD | 19062.175% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 837.831% |
| Opthea Limited | 21.72 Thousand USD | -983946.961% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 372941.294% |
| PureTech Health plc | -1.6 Million USD | 13433.437% |
| Pyxis Oncology, Inc. | -2 Million USD | 10786.75% |
| Seer, Inc. | 7.02 Million USD | -2941.625% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 2126604.825% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -2615.475% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 5521.928% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -50309.198% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -105.319% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -58.007% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 320.459% |
| ChromaDex Corporation | 50.78 Million USD | -320.904% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 92227.155% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 375.439% |
| CRISPR Therapeutics AG | 240.95 Million USD | 11.297% |
| Precision BioSciences, Inc. | 40.47 Million USD | -428.106% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 317.735% |
| Innoviva, Inc. | 261.06 Million USD | 18.13% |
| Summit Therapeutics Inc. | -2.05 Million USD | 10526.098% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -4782.024% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -892.04% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 180480.788% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 149251.088% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -34996.059% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 31.86% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -8203.613% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 421335.711% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 3111.2% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 45139.986% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 2055244.231% |
| Soligenix, Inc. | 97.31 Thousand USD | -219541.151% |
| Century Therapeutics, Inc. | -10.8 Million USD | 2077.38% |
| Kura Oncology, Inc. | -849 Thousand USD | 25274.912% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 418.513% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 145497.959% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -115.809% |
| Autolus Therapeutics plc | -4.86 Million USD | 4491.514% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -416.443% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 127323.214% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -125.642% |
| GRI Bio, Inc. | 10.84 Million USD | -1871.543% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -8314.81% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 2560.401% |
| IGM Biosciences, Inc. | -211.66 Million USD | 200.98% |
| INmune Bio, Inc. | 155 Thousand USD | -137793.548% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -245.073% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 14289.489% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 33060.703% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 730218.877% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -53067.91% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 10808.166% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 68385.942% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -126.268% |
| Verastem, Inc. | -62 Thousand USD | 344833.871% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -8677.618% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 81990.805% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -6960.951% |
| Histogen Inc. | 3.76 Million USD | -5570.868% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -36995.243% |
| Surrozen, Inc. | -27.23 Million USD | 884.925% |
| Organovo Holdings, Inc. | -5.38 Million USD | 4066.135% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 17839.111% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 933.372% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -965.904% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 10794796.97% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -3423.246% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 318484.949% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -38.08% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -146494.65% |
| Apollomics, Inc. | 127 Thousand USD | -168195.276% |
| Amarin Corporation plc | 165.54 Million USD | -29.113% |
| Mesoblast Limited | -9.81 Million USD | 2277.636% |
| Turnstone Biologics Corp. | 16.5 Million USD | -1194.893% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 293.445% |
| Synaptogenix, Inc. | -6347.00 USD | 3367596.455% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 419188.235% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -32.454% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 87.84% |
| Better Therapeutics, Inc. | -2.72 Million USD | 7931.99% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 290.561% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 36.78% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1873653.647% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 3514.297% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 19390.162% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -2820.675% |
| Insmed Incorporated | 239.63 Million USD | 10.808% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -5873.589% |
| OmniAb, Inc. | 14.66 Million USD | -1357.251% |
| Alector, Inc. | -95.05 Million USD | 324.859% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -70.143% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 591.763% |
| Zai Lab Limited | 170.9 Million USD | -25.062% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -161.044% |
| Aura Biosciences, Inc. | -1.29 Million USD | 16604.633% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -164311.538% |
| Immunic, Inc. | -111 Thousand USD | 192654.054% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -1248.146% |
| Veracyte, Inc. | 248.14 Million USD | 13.868% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 103.058% |
| FibroGen, Inc. | 128.9 Million USD | -65.809% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 37896376.596% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 1931.98% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 93.711% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -54844.73% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 39.851% |
| TG Therapeutics, Inc. | 219.1 Million USD | 2.452% |
| Galecto, Inc. | -830 Thousand USD | 25851.205% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 15532.13% |
| Fortrea Holdings Inc. | 424 Million USD | 49.591% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 348.047% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 37795.767% |
| XBiotech Inc. | -1.74 Million USD | 12355.447% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 19390.162% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 559.932% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 382.965% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -191.18% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -1172.005% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 45.061% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 530.509% |
| Vaxxinity, Inc. | -2.23 Million USD | 9667.368% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 34.588% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 1987.478% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -774.136% |
| NexImmune, Inc. | -1.02 Million USD | 20952.765% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -3957955.556% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 3107.956% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 98.109% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 319933.301% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 6119.009% |
| Ainos, Inc. | -253.73 Thousand USD | 84336.185% |
| Pluri Inc. | 322 Thousand USD | -66277.329% |
| Prothena Corporation plc | -129.2 Million USD | 265.428% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -323.876% |
| Celularity Inc. | 6.75 Million USD | -3064.101% |
| Rallybio Corporation | -150 Thousand USD | 142590.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 755.488% |
| MeiraGTx Holdings plc | 287 Thousand USD | -74372.125% |
| Omeros Corporation | -69.77 Million USD | 406.303% |
| Humacyte, Inc. | -76.55 Million USD | 379.21% |
| Immunocore Holdings plc | 248.39 Million USD | 13.952% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 1509.025% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -242.623% |
| Blueprint Medicines Corporation | 236.58 Million USD | 9.658% |
| CalciMedica, Inc. | -58 Thousand USD | 368608.621% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 15088.429% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -635.622% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 7615.295% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 792.483% |
| Pulmatrix, Inc. | -8.22 Million USD | 2700.182% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 18367.949% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 53667.669% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 153.595% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -7600.539% |
| Cytokinetics, Incorporated | -322.59 Million USD | 166.255% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -24692.224% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 62778.886% |
| Vor Biopharma Inc. | -3.49 Million USD | 6220.704% |
| Roivant Sciences Ltd. | 109.23 Million USD | -95.665% |
| Evogene Ltd. | 1.39 Million USD | -15177.698% |
| ProKidney Corp. | -3.16 Million USD | 6844.557% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 586.735% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -3017.034% |
| CorMedix Inc. | -205.56 Thousand USD | 104075.929% |
| BioLineRx Ltd. | 1.1 Million USD | -19190.162% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 371.682% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 647781.818% |
| Atai Life Sciences N.V. | -5000.00 USD | 4274800.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 175495.334% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 222740.625% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 15487.689% |
| Sagimet Biosciences Inc. | 2 Million USD | -10586.75% |
| MediciNova, Inc. | 979.7 Thousand USD | -21716.261% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 353.484% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 226143.044% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1131.501% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 12.595% |
| Biomea Fusion, Inc. | -4.2 Million USD | 5187.717% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 75.499% |
| Mereo BioPharma Group plc | 7.42 Million USD | -2778.198% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 69046.774% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 1781225.0% |
| Absci Corporation | -41.84 Million USD | 610.729% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 4274800.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 379.857% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 8784.884% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 22813.603% |
| Allakos Inc. | -6.14 Million USD | 3580.459% |
| Imunon, Inc. | -720 Thousand USD | 29785.211% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 409.779% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 55.088% |
| BioAtla, Inc. | -103.73 Million USD | 306.047% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1873653.647% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 120175.843% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 188.022% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 68825.08% |
| XOMA Corporation | 3.86 Million USD | -5435.742% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 404.965% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -1344.741% |
| aTyr Pharma, Inc. | -2.38 Million USD | 9050.377% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -1615.369% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 737117.241% |
| Viridian Therapeutics, Inc. | -1 Million USD | 21303.869% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -1644115284.615% |
| Akari Therapeutics, Plc | -4000.00 USD | 5343475.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 66.441% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -109672.069% |
| UroGen Pharma Ltd. | 73.35 Million USD | -191.383% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 900.686% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -1840856.072% |
| Orgenesis Inc. | -5.72 Million USD | 3833.362% |
| Entera Bio Ltd. | -56 Thousand USD | 381769.643% |
| GH Research PLC | -315 Thousand USD | 67952.381% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 113187.302% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 40811.429% |
| Xencor, Inc. | -85.26 Million USD | 350.686% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 96822.736% |
| Replimune Group, Inc. | -2.65 Million USD | 8150.282% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 21447.115% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -20.181% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -109672.069% |
| Portage Biotech Inc. | -54 Thousand USD | 395905.556% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 226143.044% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 56793.634% |
| OncoCyte Corporation | 413 Thousand USD | -51651.816% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 4755049.944% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 96277127.027% |
| Purple Biotech Ltd. | -196 Thousand USD | 109148.469% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -2283.307% |
| scPharmaceuticals Inc. | 9.78 Million USD | -2084.983% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 2146.299% |
| HilleVax, Inc. | -2.15 Million USD | 10013.497% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 220445.361% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 1424620.128% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 32096.257% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 929382.609% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 2847561.285% |
| Savara Inc. | -44.26 Million USD | 582.886% |
| Curis, Inc. | 9.81 Million USD | -2078.524% |
| Daré Bioscience, Inc. | 2.76 Million USD | -7617.397% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 171378.488% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 12461.77% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 93843.421% |
| BeiGene, Ltd. | 2.07 Billion USD | 89.719% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 7744.587% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 153.479% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -277.037% |
| Erasca, Inc. | -3.73 Million USD | 5827.09% |
| bluebird bio, Inc. | -4.03 Million USD | 5403.598% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 757542.058% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 88.777% |
| DBV Technologies S.A. | 15.72 Million USD | -1258.946% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 757542.058% |
| Moderna, Inc. | 2.15 Billion USD | 90.082% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 23459.016% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -2569.685% |
| Molecular Templates, Inc. | 50.39 Million USD | -324.119% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 39975.933% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -59.756% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 3535.149% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 643.261% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 292.332% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 6056.94% |
| MacroGenics, Inc. | 50.52 Million USD | -323.011% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 3605.002% |
| Prime Medicine, Inc. | -147.9 Million USD | 244.508% |
| Aditxt, Inc. | -111.66 Thousand USD | 191515.905% |
| Adagene Inc. | 18.11 Million USD | -1080.107% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -43698.156% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -52.448% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -35.416% |
| SciSparc Ltd. | 2.19 Million USD | -9632.923% |
| Vericel Corporation | 135.57 Million USD | -57.65% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 853367.596% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 689968.311% |
| Generation Bio Co. | -73.91 Million USD | 389.179% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 49009.611% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -291.32% |
| Invivyd, Inc. | -2.02 Million USD | 10639.201% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 171.046% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 206731.025% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -121.79% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -117.458% |
| ADMA Biologics, Inc. | 88.21 Million USD | -142.28% |
| Clene Inc. | 533 Thousand USD | -40000.375% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -786.529% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 22433.856% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1131.501% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -10651.258% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 110093.516% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -329.144% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 3113.748% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 25666.388% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -156.231% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -292239.151% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -302.045% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 223.412% |
| Trevena, Inc. | 1.45 Million USD | -14589.691% |
| Surrozen, Inc. | -27.23 Million USD | 884.925% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 60648.159% |
| Cingulate Inc. | -582.91 Thousand USD | 36766.392% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 689567.742% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 1185.004% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 2823547.82% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 24360.499% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 68.601% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 21733.097% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 379452.881% |
| Kronos Bio, Inc. | 1.37 Million USD | -15478.353% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 498.269% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 73296.918% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 43869.992% |
| ImmunityBio, Inc. | -17.89 Million USD | 1294.718% |
| Korro Bio, Inc. | -3.63 Million USD | 5988.017% |
| Kineta, Inc. | 5.43 Million USD | -3834.014% |
| BioVie Inc. | -229.37 Thousand USD | 93280.659% |
| Codexis, Inc. | 57.33 Million USD | -272.789% |
| Celularity Inc. | 6.75 Million USD | -3064.101% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -5226.065% |
| Celcuity Inc. | -142.77 Thousand USD | 149803.723% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -422384.681% |
| Cibus, Inc. | 1.42 Million USD | -14930.591% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 57248.396% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 1032.567% |
| IN8bio, Inc. | -2.5 Million USD | 8645.982% |
| Kodiak Sciences Inc. | -25.94 Million USD | 923.737% |
| Annexon, Inc. | -3.26 Million USD | 6642.241% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 10556.703% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 612.1% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -33296.094% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 72.546% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -23.578% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 11349.211% |
| Arcellx, Inc. | 108.27 Million USD | -97.393% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 760.308% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -169.854% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 1110.472% |
| Moolec Science SA | -143.3 Thousand USD | 149246.924% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 605.069% |
| Geron Corporation | -123.5 Million USD | 273.061% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -6402.434% |
| Royalty Pharma plc | 1.79 Billion USD | 88.085% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 404.944% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 5917458.804% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -92269.625% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 291.839% |
| Humacyte, Inc. | -76.55 Million USD | 379.21% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 22618.0% |
| 89bio, Inc. | -273 Thousand USD | 78391.209% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 17103.58% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 25304.599% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 173868.293% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -19000.536% |
| Notable Labs, Ltd. | 113 Thousand USD | -189046.018% |
| Liquidia Corporation | 14.6 Million USD | -1363.938% |
| Mustang Bio, Inc. | -2.22 Million USD | 9706.067% |
| Immunovant, Inc. | -231 Thousand USD | 92625.974% |
| Quantum-Si incorporated | 488 Thousand USD | -43698.156% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 484.699% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 712550.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -11378.786% |
| Acasti Pharma Inc. | -11 Thousand USD | 1943145.455% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 104556.13% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 33060.703% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 227.594% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -18738.249% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 56198.425% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 11015.986% |
| PepGen Inc. | -1.18 Million USD | 18151.943% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 168395.276% |
| United Therapeutics Corporation | 2.07 Billion USD | 89.675% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 1033.463% |
| Solid Biosciences Inc. | -76.56 Million USD | 379.162% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 258912.346% |
| Immuneering Corporation | -764.13 Thousand USD | 28070.733% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -322450.706% |
| Belite Bio, Inc | -399 Thousand USD | 53667.669% |
| XOMA Corporation | 3.86 Million USD | -5435.742% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 1166.755% |
| Bionomics Limited | -434.44 Thousand USD | 49296.799% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 20000.838% |
| uniQure N.V. | 2.21 Million USD | -9549.436% |
| Cassava Sciences, Inc. | -89.42 Million USD | 339.016% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 332.147% |
| Forte Biosciences, Inc. | -9000.00 USD | 2374933.333% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 25697.006% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 49009.611% |
| Altimmune, Inc. | -65.37 Million USD | 426.947% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 40.962% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 20000.838% |
| Compugen Ltd. | 31.45 Million USD | -579.495% |
| Peak Bio, Inc. | 367.76 Thousand USD | -58016.644% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -771.818% |
| Benitec Biopharma Inc. | 108 Thousand USD | -197802.778% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 274119.231% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 17866.833% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 11830.79% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 179709.244% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 17866.833% |
| Instil Bio, Inc. | -4.75 Million USD | 4594.008% |
| argenx SE | 1.1 Billion USD | 80.718% |
| Immunome, Inc. | -8.9 Million USD | 2499.63% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 11408.73% |
| Verona Pharma plc | -679.62 Thousand USD | 31549.007% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 122234.286% |
| Shattuck Labs, Inc. | -2.38 Million USD | 9061.635% |
| CervoMed Inc. | -1.29 Million USD | 16622.151% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 8979.726% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 4574.252% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -8549.737% |
| Moolec Science SA | -143.3 Thousand USD | 149246.924% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 52482.178% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 8100.478% |
| AnaptysBio, Inc. | 14.78 Million USD | -1346.012% |
| Design Therapeutics, Inc. | -537 Thousand USD | 39901.676% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 50155.035% |
| NeurAxis, Inc. | 2.15 Million USD | -9810.261% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -9859.692% |
| Lumos Pharma, Inc. | 2 Million USD | -10549.477% |
| Achilles Therapeutics plc | -4.73 Million USD | 4617.5% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 122234.286% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 202356.92% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -575.121% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -24692.224% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 20810.756% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 569.252% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -496958.14% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 26101.825% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 1624473.005% |
| Palisade Bio, Inc. | 246 Thousand USD | -86784.146% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 647781.818% |
| Beam Therapeutics Inc. | -59.67 Million USD | 458.183% |
| Neurogene Inc. | -3.26 Million USD | 6652.269% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -53.396% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 5889.139% |
| Sesen Bio, Inc. | 40 Million USD | -434.338% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 72064.646% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 5407.5% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 2334.319% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -1418.004% |
| Athira Pharma, Inc. | -969 Thousand USD | 22157.276% |
| Vaccinex, Inc. | -16 Million USD | 1435.51% |
| HCW Biologics Inc. | -574.82 Thousand USD | 37282.685% |
| XOMA Corporation | 3.86 Million USD | -5435.742% |
| Nektar Therapeutics | 53.47 Million USD | -299.669% |
| Arvinas, Inc. | 71.8 Million USD | -197.681% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 356.09% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 440.478% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 66477.329% |
| Rezolute, Inc. | -36 Thousand USD | 593808.333% |
| Clene Inc. | 533 Thousand USD | -40000.375% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 16646128.037% |
| BeyondSpring Inc. | 1.75 Million USD | -12106.453% |
| Synlogic, Inc. | -1.92 Million USD | 11208.888% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 577762.162% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 3475.474% |
| Peak Bio, Inc. | 367.76 Thousand USD | -58016.644% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 1227.116% |
| Krystal Biotech, Inc. | 47.6 Million USD | -348.976% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -51.487% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -4153.433% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 8354.806% |
| MannKind Corporation | 136.19 Million USD | -56.938% |
| Ikena Oncology, Inc. | -50.49 Million USD | 523.305% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -96.422% |
| Gossamer Bio, Inc. | -4.38 Million USD | 4974.23% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 84915.476% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 4274800.0% |
| Legend Biotech Corporation | 140.92 Million USD | -51.661% |
| Mural Oncology plc | -2.56 Million USD | 8426.256% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 38890.381% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 213835.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -929.85% |
| REGENXBIO Inc. | 53.02 Million USD | -303.053% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 4089.861% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 111203.314% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 12440.358% |
| Vaxart, Inc. | -60.76 Million USD | 451.752% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 81436.099% |
| Cellectis S.A. | 18 Thousand USD | -1187316.667% |
| Longeveron Inc. | 221 Thousand USD | -96612.67% |
| Repare Therapeutics Inc. | -80.07 Million USD | 366.935% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 80.445% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 16617.388% |
| Revolution Medicines, Inc. | -399.66 Million USD | 153.479% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 610771.429% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -436093.878% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 97.517% |
| Denali Therapeutics Inc. | -93.34 Million USD | 328.973% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 853367.596% |
| Veru Inc. | 7.56 Million USD | -2724.967% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 141646.358% |
| Cingulate Inc. | -582.91 Thousand USD | 36766.392% |
| Passage Bio, Inc. | -3.72 Million USD | 5844.02% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 1774718.067% |
| Exicure, Inc. | -1.42 Million USD | 15120.028% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 55905.483% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -7807.325% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 41790.155% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -213.735% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 142964.304% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 461.002% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -54563.683% |
| OmniAb, Inc. | 14.66 Million USD | -1357.251% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -969.049% |
| Lipocine Inc. | -2.85 Million USD | 7597.322% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 11697.124% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 3846.45% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 14289.489% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -183.784% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 328923.077% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -153.553% |
| Ocugen, Inc. | -33.53 Million USD | 737.311% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 6859.488% |
| Q32 Bio Inc. | 578 Thousand USD | -36878.374% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 80754.717% |
| Alumis Inc. Common Stock | -1.28 Million USD | 16746.028% |
| Equillium, Inc. | 35.95 Million USD | -494.402% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 12621.09% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -42589.028% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 5170274.165% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 82623.166% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -50462.795% |
| Dominari Holdings Inc. | 2.03 Million USD | -10382.344% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 116595.25% |
| vTv Therapeutics Inc. | -13.59 Million USD | 1672.159% |
| Bio-Techne Corporation | 773.07 Million USD | 72.353% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -1134.107% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 53.615% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 18383.576% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 991.305% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -1727.263% |
| Nkarta, Inc. | -5.86 Million USD | 3741.762% |
| BioCardia, Inc. | -7.24 Million USD | 3048.476% |
| Iterum Therapeutics plc | -1.75 Million USD | 12313.429% |